COVID-19: US CDC to weigh rare clot risk with J&J vaccine as use paused
J&J's single-dose shot is less widely used in the United States compared to the 185 million doses delivered of Moderna and Pfizer/BioNTech's two-shot vaccines.
A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. (photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)ByREUTERSUpdated:
